ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prescription Weight Loss Medications Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-8T12922
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Prescription Weight Loss Medications Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Prescription Weight Loss Medications Market Research Report 2025

Code: QYRE-Auto-8T12922
Report
March 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Bristol–Myers Squibb
Roche
Novo Nordisk
GlaxoSmithKline PLC
VIVUS
Currax Pharmaceuticals

Prescription Weight Loss Medications Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prescription Weight Loss Medications Market

Prescription Weight Loss Medications Market

The global market for Prescription Weight Loss Medications was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prescription Weight Loss Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Weight Loss Medications.
The Prescription Weight Loss Medications market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prescription Weight Loss Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Weight Loss Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prescription Weight Loss Medications Market Report

Report Metric Details
Report Name Prescription Weight Loss Medications Market
CAGR 5%
Segment by Type
  • Children & Teenagers
  • Adults
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Bristol-Myers Squibb, Roche, Novo Nordisk, GlaxoSmithKline, Vivus, Currax Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prescription Weight Loss Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prescription Weight Loss Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prescription Weight Loss Medications Market report?

Ans: The main players in the Prescription Weight Loss Medications Market are Pfizer, Bristol-Myers Squibb, Roche, Novo Nordisk, GlaxoSmithKline, Vivus, Currax Pharmaceuticals

What are the Application segmentation covered in the Prescription Weight Loss Medications Market report?

Ans: The Applications covered in the Prescription Weight Loss Medications Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Prescription Weight Loss Medications Market report?

Ans: The Types covered in the Prescription Weight Loss Medications Market report are Children & Teenagers, Adults

Recommended Reports

Pharmaceutical Drugs

Medical Treatments

Pharmaceutical Market Services

1 Prescription Weight Loss Medications Market Overview
1.1 Product Definition
1.2 Prescription Weight Loss Medications by Type
1.2.1 Global Prescription Weight Loss Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Children & Teenagers
1.2.3 Adults
1.3 Prescription Weight Loss Medications by Application
1.3.1 Global Prescription Weight Loss Medications Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Prescription Weight Loss Medications Market Size Estimates and Forecasts
1.4.1 Global Prescription Weight Loss Medications Revenue 2020-2031
1.4.2 Global Prescription Weight Loss Medications Sales 2020-2031
1.4.3 Global Prescription Weight Loss Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prescription Weight Loss Medications Market Competition by Manufacturers
2.1 Global Prescription Weight Loss Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prescription Weight Loss Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prescription Weight Loss Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prescription Weight Loss Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prescription Weight Loss Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription Weight Loss Medications, Product Type & Application
2.7 Global Key Manufacturers of Prescription Weight Loss Medications, Date of Enter into This Industry
2.8 Global Prescription Weight Loss Medications Market Competitive Situation and Trends
2.8.1 Global Prescription Weight Loss Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prescription Weight Loss Medications Players Market Share by Revenue
2.8.3 Global Prescription Weight Loss Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prescription Weight Loss Medications Market Scenario by Region
3.1 Global Prescription Weight Loss Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prescription Weight Loss Medications Sales by Region: 2020-2031
3.2.1 Global Prescription Weight Loss Medications Sales by Region: 2020-2025
3.2.2 Global Prescription Weight Loss Medications Sales by Region: 2026-2031
3.3 Global Prescription Weight Loss Medications Revenue by Region: 2020-2031
3.3.1 Global Prescription Weight Loss Medications Revenue by Region: 2020-2025
3.3.2 Global Prescription Weight Loss Medications Revenue by Region: 2026-2031
3.4 North America Prescription Weight Loss Medications Market Facts & Figures by Country
3.4.1 North America Prescription Weight Loss Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prescription Weight Loss Medications Sales by Country (2020-2031)
3.4.3 North America Prescription Weight Loss Medications Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prescription Weight Loss Medications Market Facts & Figures by Country
3.5.1 Europe Prescription Weight Loss Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prescription Weight Loss Medications Sales by Country (2020-2031)
3.5.3 Europe Prescription Weight Loss Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription Weight Loss Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Prescription Weight Loss Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prescription Weight Loss Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Prescription Weight Loss Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prescription Weight Loss Medications Market Facts & Figures by Country
3.7.1 Latin America Prescription Weight Loss Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prescription Weight Loss Medications Sales by Country (2020-2031)
3.7.3 Latin America Prescription Weight Loss Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prescription Weight Loss Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription Weight Loss Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prescription Weight Loss Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prescription Weight Loss Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prescription Weight Loss Medications Sales by Type (2020-2031)
4.1.1 Global Prescription Weight Loss Medications Sales by Type (2020-2025)
4.1.2 Global Prescription Weight Loss Medications Sales by Type (2026-2031)
4.1.3 Global Prescription Weight Loss Medications Sales Market Share by Type (2020-2031)
4.2 Global Prescription Weight Loss Medications Revenue by Type (2020-2031)
4.2.1 Global Prescription Weight Loss Medications Revenue by Type (2020-2025)
4.2.2 Global Prescription Weight Loss Medications Revenue by Type (2026-2031)
4.2.3 Global Prescription Weight Loss Medications Revenue Market Share by Type (2020-2031)
4.3 Global Prescription Weight Loss Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prescription Weight Loss Medications Sales by Application (2020-2031)
5.1.1 Global Prescription Weight Loss Medications Sales by Application (2020-2025)
5.1.2 Global Prescription Weight Loss Medications Sales by Application (2026-2031)
5.1.3 Global Prescription Weight Loss Medications Sales Market Share by Application (2020-2031)
5.2 Global Prescription Weight Loss Medications Revenue by Application (2020-2031)
5.2.1 Global Prescription Weight Loss Medications Revenue by Application (2020-2025)
5.2.2 Global Prescription Weight Loss Medications Revenue by Application (2026-2031)
5.2.3 Global Prescription Weight Loss Medications Revenue Market Share by Application (2020-2031)
5.3 Global Prescription Weight Loss Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Prescription Weight Loss Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Prescription Weight Loss Medications Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Company Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Prescription Weight Loss Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Prescription Weight Loss Medications Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Prescription Weight Loss Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Prescription Weight Loss Medications Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Company Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Prescription Weight Loss Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novo Nordisk Prescription Weight Loss Medications Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Prescription Weight Loss Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Prescription Weight Loss Medications Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Vivus
6.6.1 Vivus Company Information
6.6.2 Vivus Description and Business Overview
6.6.3 Vivus Prescription Weight Loss Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vivus Prescription Weight Loss Medications Product Portfolio
6.6.5 Vivus Recent Developments/Updates
6.7 Currax Pharmaceuticals
6.7.1 Currax Pharmaceuticals Company Information
6.7.2 Currax Pharmaceuticals Description and Business Overview
6.7.3 Currax Pharmaceuticals Prescription Weight Loss Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Currax Pharmaceuticals Prescription Weight Loss Medications Product Portfolio
6.7.5 Currax Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prescription Weight Loss Medications Industry Chain Analysis
7.2 Prescription Weight Loss Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription Weight Loss Medications Production Mode & Process Analysis
7.4 Prescription Weight Loss Medications Sales and Marketing
7.4.1 Prescription Weight Loss Medications Sales Channels
7.4.2 Prescription Weight Loss Medications Distributors
7.5 Prescription Weight Loss Medications Customer Analysis
8 Prescription Weight Loss Medications Market Dynamics
8.1 Prescription Weight Loss Medications Industry Trends
8.2 Prescription Weight Loss Medications Market Drivers
8.3 Prescription Weight Loss Medications Market Challenges
8.4 Prescription Weight Loss Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Bristol–Myers Squibb
Roche
Novo Nordisk
GlaxoSmithKline PLC
VIVUS
Currax Pharmaceuticals
List of Tables
 Table 1. Global Prescription Weight Loss Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prescription Weight Loss Medications Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prescription Weight Loss Medications Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prescription Weight Loss Medications Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prescription Weight Loss Medications Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prescription Weight Loss Medications Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prescription Weight Loss Medications Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prescription Weight Loss Medications Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prescription Weight Loss Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prescription Weight Loss Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prescription Weight Loss Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Prescription Weight Loss Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prescription Weight Loss Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Weight Loss Medications as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prescription Weight Loss Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prescription Weight Loss Medications Sales by Region (2020-2025) & (Units)
 Table 18. Global Prescription Weight Loss Medications Sales Market Share by Region (2020-2025)
 Table 19. Global Prescription Weight Loss Medications Sales by Region (2026-2031) & (Units)
 Table 20. Global Prescription Weight Loss Medications Sales Market Share by Region (2026-2031)
 Table 21. Global Prescription Weight Loss Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prescription Weight Loss Medications Revenue Market Share by Region (2020-2025)
 Table 23. Global Prescription Weight Loss Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prescription Weight Loss Medications Revenue Market Share by Region (2026-2031)
 Table 25. North America Prescription Weight Loss Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prescription Weight Loss Medications Sales by Country (2020-2025) & (Units)
 Table 27. North America Prescription Weight Loss Medications Sales by Country (2026-2031) & (Units)
 Table 28. North America Prescription Weight Loss Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prescription Weight Loss Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prescription Weight Loss Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prescription Weight Loss Medications Sales by Country (2020-2025) & (Units)
 Table 32. Europe Prescription Weight Loss Medications Sales by Country (2026-2031) & (Units)
 Table 33. Europe Prescription Weight Loss Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prescription Weight Loss Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prescription Weight Loss Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prescription Weight Loss Medications Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Prescription Weight Loss Medications Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Prescription Weight Loss Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prescription Weight Loss Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prescription Weight Loss Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prescription Weight Loss Medications Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Prescription Weight Loss Medications Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Prescription Weight Loss Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prescription Weight Loss Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prescription Weight Loss Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prescription Weight Loss Medications Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Prescription Weight Loss Medications Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Prescription Weight Loss Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prescription Weight Loss Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prescription Weight Loss Medications Sales (Units) by Type (2020-2025)
 Table 51. Global Prescription Weight Loss Medications Sales (Units) by Type (2026-2031)
 Table 52. Global Prescription Weight Loss Medications Sales Market Share by Type (2020-2025)
 Table 53. Global Prescription Weight Loss Medications Sales Market Share by Type (2026-2031)
 Table 54. Global Prescription Weight Loss Medications Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prescription Weight Loss Medications Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prescription Weight Loss Medications Revenue Market Share by Type (2020-2025)
 Table 57. Global Prescription Weight Loss Medications Revenue Market Share by Type (2026-2031)
 Table 58. Global Prescription Weight Loss Medications Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prescription Weight Loss Medications Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prescription Weight Loss Medications Sales (Units) by Application (2020-2025)
 Table 61. Global Prescription Weight Loss Medications Sales (Units) by Application (2026-2031)
 Table 62. Global Prescription Weight Loss Medications Sales Market Share by Application (2020-2025)
 Table 63. Global Prescription Weight Loss Medications Sales Market Share by Application (2026-2031)
 Table 64. Global Prescription Weight Loss Medications Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prescription Weight Loss Medications Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prescription Weight Loss Medications Revenue Market Share by Application (2020-2025)
 Table 67. Global Prescription Weight Loss Medications Revenue Market Share by Application (2026-2031)
 Table 68. Global Prescription Weight Loss Medications Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prescription Weight Loss Medications Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Prescription Weight Loss Medications Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Prescription Weight Loss Medications Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Bristol-Myers Squibb Company Information
 Table 76. Bristol-Myers Squibb Description and Business Overview
 Table 77. Bristol-Myers Squibb Prescription Weight Loss Medications Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bristol-Myers Squibb Prescription Weight Loss Medications Product
 Table 79. Bristol-Myers Squibb Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche Prescription Weight Loss Medications Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Prescription Weight Loss Medications Product
 Table 84. Roche Recent Developments/Updates
 Table 85. Novo Nordisk Company Information
 Table 86. Novo Nordisk Description and Business Overview
 Table 87. Novo Nordisk Prescription Weight Loss Medications Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novo Nordisk Prescription Weight Loss Medications Product
 Table 89. Novo Nordisk Recent Developments/Updates
 Table 90. GlaxoSmithKline Company Information
 Table 91. GlaxoSmithKline Description and Business Overview
 Table 92. GlaxoSmithKline Prescription Weight Loss Medications Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Prescription Weight Loss Medications Product
 Table 94. GlaxoSmithKline Recent Developments/Updates
 Table 95. Vivus Company Information
 Table 96. Vivus Description and Business Overview
 Table 97. Vivus Prescription Weight Loss Medications Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Vivus Prescription Weight Loss Medications Product
 Table 99. Vivus Recent Developments/Updates
 Table 100. Currax Pharmaceuticals Company Information
 Table 101. Currax Pharmaceuticals Description and Business Overview
 Table 102. Currax Pharmaceuticals Prescription Weight Loss Medications Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Currax Pharmaceuticals Prescription Weight Loss Medications Product
 Table 104. Currax Pharmaceuticals Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Prescription Weight Loss Medications Distributors List
 Table 108. Prescription Weight Loss Medications Customers List
 Table 109. Prescription Weight Loss Medications Market Trends
 Table 110. Prescription Weight Loss Medications Market Drivers
 Table 111. Prescription Weight Loss Medications Market Challenges
 Table 112. Prescription Weight Loss Medications Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prescription Weight Loss Medications
 Figure 2. Global Prescription Weight Loss Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prescription Weight Loss Medications Market Share by Type: 2024 & 2031
 Figure 4. Children & Teenagers Product Picture
 Figure 5. Adults Product Picture
 Figure 6. Global Prescription Weight Loss Medications Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Prescription Weight Loss Medications Market Share by Application: 2024 & 2031
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Prescription Weight Loss Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Prescription Weight Loss Medications Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Prescription Weight Loss Medications Sales (2020-2031) & (Units)
 Figure 13. Global Prescription Weight Loss Medications Average Price (US$/Unit) & (2020-2031)
 Figure 14. Prescription Weight Loss Medications Report Years Considered
 Figure 15. Prescription Weight Loss Medications Sales Share by Manufacturers in 2024
 Figure 16. Global Prescription Weight Loss Medications Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Prescription Weight Loss Medications Players: Market Share by Revenue in Prescription Weight Loss Medications in 2024
 Figure 18. Prescription Weight Loss Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Prescription Weight Loss Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Prescription Weight Loss Medications Sales Market Share by Country (2020-2031)
 Figure 21. North America Prescription Weight Loss Medications Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Prescription Weight Loss Medications Sales Market Share by Country (2020-2031)
 Figure 25. Europe Prescription Weight Loss Medications Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Prescription Weight Loss Medications Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Prescription Weight Loss Medications Revenue Market Share by Region (2020-2031)
 Figure 33. China Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Prescription Weight Loss Medications Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Prescription Weight Loss Medications Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Prescription Weight Loss Medications Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Prescription Weight Loss Medications Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Prescription Weight Loss Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Prescription Weight Loss Medications by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Prescription Weight Loss Medications by Type (2020-2031)
 Figure 55. Global Prescription Weight Loss Medications Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Prescription Weight Loss Medications by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Prescription Weight Loss Medications by Application (2020-2031)
 Figure 58. Global Prescription Weight Loss Medications Price (US$/Unit) by Application (2020-2031)
 Figure 59. Prescription Weight Loss Medications Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Weight loss Drugs Market Insights Forecast to 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hair Loss Growth Treatment Market Research Report 2025
Global Cholesterol Lowering Drugs Market Research Report 2024
Global Antidepressant Medication Market Research Report 2025
Global Sleeping Pills Prescription Drugs Market Research Report 2025
Hair Loss Treatment for Man Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Sleeping Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cholesterol Reducer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weekly Pill Organizer Market Research Report 2025
Global Pill Organizer with Timer Reminder Market Research Report 2025
Global Gynecological Cancers Drug Market Research Report 2025
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weight Reduction Medicine Market Research Report 2024
Diet Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polycystic Ovary Syndrome PCOS Drugs Market Research Report 2024
Global Treatment Planning Software Market Research Report 2025
Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024
Global Diagnostic Guidewire Market Research Report 2024

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Medication for Facial Features Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4D16704
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions